Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: A prospective study

Head and Face Medicine

Volumn 5, Issue 1, 2009, Pages

  Upile, Tahwinder ^a,b,c   Elmiyeh, Behrad ^a   Jerjes, Waseem ^b,c   Prasad, Vyas ^a   Kafas, Panagiotis ^d   Abiola, Jesuloba ^c   Youl, Bryan ^a   Epstein, Ruth ^a   Hopper, Colin ^b,c   Sudhoff, Holger ^e   Rubin, John ^a  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e OWL University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; MUSCLE RELAXANT AGENT;

ANALYSIS OF VARIANCE; ARTICLE; DYSPHONIA; ELECTROMYOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MUSCLE SPASM; PATHOPHYSIOLOGY; PHONATION; PROSPECTIVE STUDY; VOICE;

ANALYSIS OF VARIANCE; BOTULINUM TOXINS; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PHONATION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPASM; VOICE DISORDERS; VOICE QUALITY;

EID: 70450255211     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-5-20     Document Type: Article

References (34)

1. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. A Blitzer MF Brin CF Stewart, Laryngoscope 1998 108 10 1435 41 10.1097/00005537-199810000-00003 9778279
2. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. RH Miller GE Woodson J Jankovic, Arch Otolaryngol Head Neck Surg 1987 113 6 603 5 3566940
3. Successful treatment of selected cases of abductor spasmodic dysphonia using Botulinum toxin injection. CL Ludlow RF Naunton S Terada BJ Anderson, Otolaryngol Head Neck Surg 1991 104 6 849 55 1908979
4. Comparison of Botulinum toxin injection procedures in adductor spasmodic dysphonia. SG Adams EJ Hunt JC Irish DA Charles AE Lang LC Durkin DL Wong, J Otolaryngol 1995 24 6 345 51 8699600
5. Botulinum toxin injection and airflow stability in spasmodic dysphonia. G Cantarella A Berlusconi B Maraschi A Ghio S Barbieri, Otolaryngol Head Neck Surg 2006 134 3 419 23 10.1016/j.otohns.2005.10.028 16500438
6. Outcomes assessment following treatment of spasmodic dysphonia with Botulinum toxin. MS Courey CG Garrett CR Billante RE Stone MD Portell TL Smith JL Netterville, Ann Otol Rhinol Laryngol 2000 109 9 819 22 11007083
7. The action of Botulinum toxin on the neuromuscular junction. ASV Burgen F Dickens LJ Zamata, J Physiol (Lond) 1949 109 10 24 15394302
8. Measurement of laryngeal resistance in the evaluation of Botulinum toxin injection for treatment of focal laryngeal dystonia. DL Witsell MC Weissler MK Donovan JF Howard Jr SJ Martinkosky, Laryngoscope 1994 104 1 Pt 1 8 11 8295461
9. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia. DS Lundy FL Lu RR Casiano JW Xue, J Voice 1998 12 4 460 6 10.1016/S0892-1997(98)80055-6 9988033
10. Unilateral versus bilateral injections of Botulinum toxin in patients with adductor spasmodic dysphonia. S Bielamowicz SV Stager A Badillo A Godlewski, J Voice 2002 16 1 117 23 10.1016/S0892-1997(02)00080-2 12002878
11. A comparison of the efficacy of unilateral versus bilateral Botulinum toxin injections in the treatment of adductor spasmodic dysphonia. AP Maloney MD Morrison, J Otolaryngol 1994 23 3 160 4 8064952
12. Laryngeal dystonia: a series with Botulinum toxin therapy. A Blitzer MF Brin, Ann Otol Rhinol Laryngol 1991 100 2 85 9 1992905
13. Prospective study of patients' subjective responses to Botulinum toxin injection for spasmodic dysphonia. TC Liu JC Irish SG Adams LC Durkin EJ Hunt, J Otolaryngol 1996 25 2 66 74 8683655
14. A comparison of bilateral and unilateral Botulinum toxin treatments for spasmodic dysphonia. P Zwirner T Murry GE Woodson, Eur Arch Otorhinolaryngol 1993 250 5 271 6 10.1007/BF00186224 8217128
15. Botulinum neurotoxin - from laboratory to bedside. KA Foster H Bigalke KR Aoki, Neurotox Res 2006 9 2-3 133 40 10.1007/BF03033931 16785110
16. Unilateral versus bilateral Botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. SG Adams EJ Hunt DA Charles AE Lang, J Otolaryngol 1993 22 3 171 5 8371328
17. Development of resistance to Botulinum toxin type A in patients with torticollis. P Greene S Fahn B Diamond, Mov Disord 1994 9 2 213 7 10.1002/mds.870090216 8196686
18. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia. A Blitzer, Otolaryngol Head Neck Surg 2005 133 6 836 8 10.1016/j.otohns.2005.09.008 16360499
19. Meta-analysis of Botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies. R Whurr C Nye M Lorch, Int J Lang Commun Disord 1998 33 Suppl 327 9 10343714
20. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. C Watts C Nye R Whurr, Clin Rehabil 2006 20 2 112 22 10.1191/0269215506cr931oa 16541931
21. Botox treatment in adductor spasmodic dysphonia: a meta-analysis. F Boutsen MP Cannito M Taylor B Bender, J Speech Lang Hear Res 2002 45 3 469 81 10.1044/1092-4388(2002/037) 12069000
22. Pharmacology of Botulinum toxin: differences between type A preparations. RL Rosales H Bigalke D Dressler, Eur JNeurol 2006 13 Suppl 1 2 10.1111/j.1468-1331.2006.01438.x
23. Pharmacokinetic properties of different formulations of Botulinum neurotoxin type A. K Wohlfarth K Kampe H Bigalke, Mov Disord 2004 19 Suppl 8 65 7 10.1002/mds.20012 15027057
24. A comparison of different injection techniques in the treatment of spasmodic dysphonia with Botulinum toxin. CL Ludlow JA Bagley SG Yin J Koda, J Voice 1992 6 380 386 10.1016/S0892-1997(05)80038-4
25. Comparison of Botulinum toxin injection procedures in adductor spasmodic dysphonia. SG Adams EJ Hunt JC Irish DA Charles AE Lang LC Durkin DL Wong, J Otolaryngol 1995 24 6 345 51 8699600
26. Effects of Botulinum toxin on pathophysiology in spasmodic dysphonia. S Bielamowicz CL Ludlow, Ann Otol Rhinol Laryngol 2000 109 2 194 203 10685573
27. Long-term effects of Botulinum toxin injections in spasmodic dysphonia. BJ Davidson CL Ludlow, Ann Otol Rhinol Laryngol 1996 105 1 33 42 8546422
28. Botulinum A toxin injection. Failures in clinical practice and a biomechanical system for the study of toxin-induced paralysis. JB Holds SG Fogg RL Anderson, Ophthal Plast Reconstr Surg 1990 6 4 252 9 2271481
29. Effects of Botulinum toxin type A on intracortical inhibition in patients with dystonia. F Gilio A Curra C Lorenzano N Modugno M Manfredi A Berardelli, Ann Neurol 2000 48 1 20 6 10.1002/1531-8249(200007)48:1<20::AID-ANA5>3.0. CO;2-U 10894212
30. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. M Simonetta Moreau C Cauhepe JP Magues JM Senard, Br J Dermatol 2003 149 5 1041 5 10.1111/j.1365-2133.2003.05620.x 14632812
31. Dose response of topical anesthetic on laryngeal neuromuscular electrical transmission. A Chitkara T Meyer A Cultrara A Blitzer, Ann Otol Rhinol Laryngol 2005 114 11 819 21 16358599
32. Comparison of concentric needle versus hooked-wire electrodes in the canine larynx. DM Jaffe NP Solomon RA Robinson HT Hoffman ES Luschei, Otolaryngol Head Neck Surg 1998 118 5 655 62 10.1016/S0194-5998(98)70236-0 9591865
33. AAEM Laryngeal Task Force. Laryngeal electromyography: an evidence-based review. RT Sataloff S Mandel EA Mann CL Ludlow, Muscle Nerve 2003 28 6 767 72 10.1002/mus.10503 14639595
34. Unilateral versus bilateral injections of Botulinum toxin in patients with adductor spasmodic dysphonia. S Bielamowicz SV Stager A Badillo A Godlewski, J Voice 2002 16 117 123 10.1016/S0892-1997(02)00080-2 12002878